Isoflurane and coronary heart disease

Anaesthesia

Volumn 57, Issue 4, 2002, Pages 338-347

  Agnew, Neil M ^a   Pennefather, S H ^a   Russell, G N ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Anaesthetics, volatile; isoflurane; Heart; coronary occlusion, ischaemia, myocardial function, blood flow (myocardial)

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANESTHETIC AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; DESFLURANE; ENFLURANE; FENTANYL; FREE RADICAL; GLIBENCLAMIDE; HALOTHANE; INHALATION ANESTHETIC AGENT; INOTROPIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; KETAMINE; PENTOBARBITAL; PHOSPHODIESTERASE INHIBITOR; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROPOFOL; SEVOFLURANE; SULFONYLUREA DERIVATIVE;

ARTERY STEAL SYNDROME; CALCIUM HOMEOSTASIS; CORONARY ARTERY BYPASS GRAFT; DRUG CHOICE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EXPERIMENTAL ANIMAL; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERFUSION PRESSURE; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANESTHETICS, INHALATION; CARDIOTONIC AGENTS; CORONARY DISEASE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

EID: 0036211255     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2002.02469.x     Document Type: Review

References (68)

1. Anesthetic-induced myocardial ischaemia: The isoflurane-coronary steal controversy
2. The prevalence of steal-prone coronary anatomy in patients with coronary artery disease: An analysis of the coronary artery surgery study registry
3. Effects of steal-prone anatomy on intraoperative myocardial ischaemia
4. Alterations in collateral blood flow produced by isoflurane in a chronically instrumented canine model of multivessel coronary artery disease
5. Comparative coronary vascular reactivity and haemodynamics during halothane and isoflurane anesthesia in swine
6. Isoflurane - A powerful coronary vasodilator in patients with coronary artery disease
7. Global and regional blood flow and metabolism during equipotent halothane and isoflurane anesthesia in patients with coronary artery disease
8. Effects of isoflurane and halothane on coronary vascular resistance and collateral myocardial blood flow: Their capacity to induce coronary steal
9. Regional blood flow and tissue oxygen pressures or the collateral-dependant myocardium during isoflurane anesthesia in dogs
10. Steal-prone coronary anatomy and myocardial ischaemia associated with four primary anaesthetic agents in humans
11. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury
12. Causative role of oxyradicals in myocardial stunning: A proven hypothesis
13. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options
14. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane
15. Comparative effects of halothane, enflurane, isoflurane and sevoflurane on function and metabolism in the ischaemic rat heart
16. ATP sparing effect of isoflurane during ischaemia and reperfusion of the canine heart
17. Beneficial effects of volatile anesthetics on decrease in coronary flow and myocardial contractility induced by oxygen-derived free radicals in isolated rabbit hearts
18. 2+ mobilisation in human neutrophils by halothane, enflurane and isoflurane
19. Influence of isoflurane and sevoflurane on metabolism of oxygen free radicals in cardiac valve replacement
20. Inhibition of sodium/calcium exchange and calcium channels of heart cells by volatile anesthetics
21. 2+ release channel of cardiac sarcoplasmic reticulum by volatile anesthetics
22. Halothane, enflurane and isoflurane inhibit sodium/proton exchange in mammalian erythrocytes
23. Four brief periods of myocardial ischaemia cause no cumulative ATP loss or necrosis
24. Preconditioning with ischaemia: A delay of lethal cell injury in ischemic myocardium
25. Ischemic preconditioning: Exploring the paradox
26. Ischaemic preconditioning in humans. Models, mediators and clinical relevance
27. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery
28. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?
29. Adaptation to ischaemia during percutaneous transluminal angioplasty. Clinical, haemodynamic and metabolic features
30. Isoflurane mimics ischaemic preconditioning via activation of K (ATP) channels: Reduction of myocardial infarct size with an acute memory phase
31. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery
32. Activation of adenosine triphosphate-regulated potassium channels: Mediation of cellular and organ protection
33. Properties and functions of ATP-sensitive K-channels
34. Oral sulfonylurea hypoglycaemic agents prevent ischaemic preconditioning in human myocardium. Two paradoxes revisited
35. The sulphonylurea controversy: More questions from the heart
36. ATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium
37. Mitochondrial ATP-dependant potassium channels: Novel effectors of cardioprotection?
38. Role of adenosine in isoflurane-induced cardioprotection
39. Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels
40. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins
41. Isoflurane-enhanced recovery of canine stunned myocardium: Role for protein kinase C?
42. Volatile anesthetics protect the ischaemic rabbit myocardium from infarction
43. Preconditioning of isolated rat heart is mediated by protein kinase C
44. Sevoflurane mimics ischaemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts
45. Ischemic preconditioning decreases postischemic myocardial tumour necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning
46. The effects of isoflurane on the secretion of TNF-alpha and IL-1 beta from LPS-stimulated human peripheral blood monocytes
47. Ischemic preconditioning, myocardial stunning and anesthesia
48. Sevoflurane protects stunned myocardium through activation of mitochondrial ATP-sensitive potassium channels
49. Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: Comparison with halothane
50. Anesthetic modulation of myocardial ischemia and reperfusion injury in pigs: Comparison between halothane and sevoflurane
51. Administration of sevoflurane and isoflurane prior to prolonged global ischaemia improves heart function in isolated rat heart
52. Recovery from myocardial stunning is faster with desflurane compared with propofol in chronically instrumented dogs
53. Propofol, but not etomidate, reduces desflurane-mediated sympathetic activation in humans
54. The direct effects of enflurane on coronary blood flow, myocardial oxygen consumption, and myocardial segmental shortening in in-situ canine hearts
55. Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart
56. Direct coronary vasomotor effects of sevoflurane and desflurane in in-situ canine hearts
57. Ketamine, but not S(+)-ketamine, blocks ischemic pre-conditioning in rabbit hearts in vivo
58. Functional recovery of stunned myocardium is greater with halothane than fentanyl anaesthesia in dogs
59. Cardioprotective effects of propofol and sevoflurane in ischaemic and reperfused rat hearts. Role of K (ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide)
60. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition
61. A comparison of the effects of fentanyl and propofol on left ventricular contractility during myocardial stunning
62. Comparison of the effects of propofol and halothane on acute myocardial ischaemia and myocardial reperfusion injury
63. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart
64. Interaction between anesthetics and the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) in ischaemic and reperfused rat hearts
65. Pharmacology and clinical assessment of cariporide for the treatment of coronary artery diseases
66. Therapeutic coma or neuroprotection by anaesthetics
67. + ATP channel and protein kinase C